Widex introduces My Sound: A New Portfolio of AI-enabled Features for Customization of Its Industry-leading Widex MOMENT™ Hearing Aids

Widex reports: Building on the success of the revolutionary, artificial intelligence-based SoundSense Learn technology, the company announced Widex My Sound, a portfolio of AI features including a new solution that instantly enables intelligent customization of the company’s cutting-edge Widex MOMENT hearing aids based on a users’ activity and listening intent.

Widex was the first company to enable user-driven sound personalization by leveraging artificial intelligence in hearing aids. Now, within My Sound, Widex launches the third generation of its AI technology, vastly improving the usability of the AI solution based on the extensive data the company has gathered from the previous two generations.

This new AI solution further combines the capacity of artificial intelligence with users’ personal real-world experience to deliver another level of automated customization. Through AI modeling and clustering of data collected via the Widex SoundSense Learn AI engine, highly qualified sound profile recommendations for the individual user can now be made based on the intent, need, and preferences of thousands of users in similar real-world situations.

“Widex is leading the industry by combining artificial intelligence and human intelligence to create natural sound experiences and foster social participation through better hearing,” said Jodi Sasaki-Miraglia, AuD, Widex’s Director of Professional Training and Education. “Once Widex Moment is fit properly by a local licensed hearing care professional, the user can, if necessary, customize their hearing aids with ease, choosing from multiple AI features. Plus, our latest generation delivers results in just seconds, putting control and intelligent personalization into the hands of every user.”

My Sound is integrated into the Widex MOMENT app and is the home for all the powerful AI personalization Widex offers. The latest generation of AI utilizes the cloud-based user data of Widex users worldwide to make sound profile recommendations based on an individual user’s current activity and listening intent. Users launch My Sound from the app and begin by selecting their activity, such as dining, then choosing their intent, such as socializing, conversation, or enjoying music.

Based on the user’s selections, Widex can draw on tens of thousands of real-life data points, reflecting the preferences and listening situations of other Widex users who have used the app previously. In seconds, the user is presented with two recommendations, which can both be listened to before selecting the settings that sound best. In the event neither recommendation meets the individual user’s needs, they can launch SoundSense Learn from the same screen to further personalize their hearing experience through that solution’s sophisticated A/B testing process.

Widex has created a radically different way of delivering hearing solutions for today’s active hearing aid user,” Sasaki-Miraglia continued. “Instead of having to program the hearing aid in a way that covers all situations the user might encounter, the hearing care professional ensures the best possible starting point for the user and My Sound then allows users to personalize their experience in real life, easily and instantly. In this way, the hearing solution adapts to the user’s preferences and becomes even more personal.”

The Widex MOMENT app, including My Sound with SoundSense Learn, is available for Apple and Android devices and is designed to work with Widex MOMENT Bluetooth hearing aids.

SourceWidex

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”